Histamine serves as the endogenous ligand for the class of G protein-coupled receptors known as histamine receptors. The H1 receptor, H2 receptor, H3 receptor, and H4 receptor are the four recognized histamine receptors. A member of the family of G-protein-coupled receptors that resemble Rhodopsin is the histamine receptor H1. This receptor, specifically expressed in smooth muscles, vascular endothelial cells, the heart, and the central nervous system, is triggered by the biogenic amine histamine and is found throughout the body. Gs mediates the positive coupling of H2 receptors to adenylate cyclase. It is a strong inducer of cAMP synthesis, which activates Protein Kinase A. Histamine H3 receptors act as autoreceptors in presynaptic histaminergic neurons and regulate histamine turnover by feedback inhibition of histamine synthesis and release. They are expressed in the central nervous system and to a lesser extent the peripheral nervous system. It has been demonstrated that the mast cell chemotaxis and eosinophil shape change are both mediated by the histamine H4 receptor.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V121176 | (+)-Dropropizine | 99291-24-4 | (+)-Dropropizine is an isomer of fluproizine and is an orally effective histamine receptor inhibitor with anti-allergic effects. |
|
V98157 | (R)-(+)-Mequitazine | 147780-50-5 | (R)-(+)-Mequitazine is a histamine H1 receptor antagonist that is biotransformed primarily through human liver microsomes to produce hydroxylated and S-oxidized metabolites. |
|
V121898 | (R)-Azelastine hydrochloride | 153408-28-7 | (R)-Azelastine hydrochloride is an antihistamine that has been shown to downregulate the levels of H1R, M1R, and M3R while inhibiting the proliferation of HNEpC. |
|
V70329 | (R)-Meclizine | 189298-48-4 | (R)-Meclizine is the R form enantiomer of Meclizine. |
|
V122155 | (S)-Cetirizine dihydrochloride | 163837-48-7 | (S)-Cetirizine dihydrochloride is an orally effective histamine H1 receptor antagonist with a Ki value of 39.1 nM. |
|
V101613 | (S)-Setastine | (S)-Setastine ((S)-EGIS-2062 free acid) is a non-sedating, highly potent H1 receptor antagonist. | |
|
V70364 | (Z)-Lafutidine ((Z)-FRG-8813) | 206449-93-6 | (Z)-Lafutidine ((Z)-FRG-8813) is a histamine H2 receptor antagonist that exerts mucoprotective effects on sensory afferent neurons and has antisecretory and gastroprotective activities. |
|
V86642 | (±)-Carbinoxamine | 486-16-8 | (±)-Carbinoxamine is a histamine H1 receptor antagonist. |
|
V106767 | 1-Methyl-4-imidazoleacetic acid hydrochloride | 35454-39-8 | 1-Methyl-4-imidazoleacetic acid hydrochloride is a stable metabolite of histamine, produced by oxidation of the major metabolite N-methylhistamine. |
|
V70328 | 4'-O-Methylnyasol (Ellisinin A) | 79004-25-4 | 4'-O-Methylnyasol is an inhibitor (blocker/antagonist) of β-hexosaminidase. |
|
V70347 | 4-Methylhistamine | 36507-31-0 | 4-Methylhistamine is a potent agonist of the histamine 4 receptor (H4R). |
|
V70315 | 4-Methylhistamine dihydrochloride | 36376-47-3 | 4-Methylhistamine (di-HCl) is a potent agonist of the histamine 4 receptor (H4R). |
|
V70326 | 4-Methylhistamine hydrochloride | 84103-51-5 | 4-Methylhistamine ( HCl) is a potent, high-affinity H4 receptor agonist. |
|
V127464 | 6-O-Senesioyl plenolin | 90042-11-8 | 6-O-Senesioyl plenolin is a sesquiterpene lactone found in the small centipede (Centipeda minima) and has anti-allergic activity. |
|
V116249 | A-423579 | 461045-17-0 | A-423579 is an orally effective non-imidazolium histamine H3 receptor antagonist. |
|
V70327 | A-943931 | 1027330-97-7 | A-943931 is a potent and specific histamine H4 receptor antagonist (inhibitor) with Kis of 4.6 and 3.8 nM for human and rat H4R, respectively. |
|
V70332 | A-987306 | 1082954-71-9 | A-987306 is a highly effective, orally bioactive histamine H4 antagonist (inhibitor) with Kis of 3.4 nM and 5.8 nM for rat and human H4, respectively. |
|
V110927 | AA 344 | 50743-49-2 | AA 344 is an orally effective antihistamine. |
|
V4406 | ABT-239 | 460746-46-7 | ABT-239 is a novel, highly efficacious, non-imidazole class of H3R antagonist and a transient receptor potential vanilloid type 1 (TRPV1) antagonist/inverse agonist developed by Abbott with stimulant and nootropic effects, and has been investigated as a treatment for ADHD, Alzheimer's disease, and schizophrenia. |
|
V103785 | ADS031 | ADS031 is a histamine H3R antagonist with an affinity of 12.5 nM for hH3R and has the highest inhibitory activity against AChE (IC50 = 1.537 μM). |